best price Risdiplam 99% see COA kanbei
GMP ISO 3 Inquiries
1825352-65-5
99%
qingdao
kanbei
25kg/bag
2022-08-31
PVC resin,pvc paste resin,melamine
-
Product Description
-
Seller Information
-
Inquiry History
-
DescriptionECHEMI Editorial ReferenceRisdiplam is an orally bioavailable mRNA splicing modifier used for the treatment of spinal muscular atrophy (SMA). It increases systemic SMN protein concentrations by improving the efficiency of SMN2 gene transcription. This mechanism of action is similar to its predecessor [nusinersen], the biggest difference being their route of administration: nusinersen requires intrathecal administration, as does the one-time gene therapy [onasemnogene abeparvovec], whereas risdiplam offers the ease of oral bioavailability. Risdiplam was approved by the FDA in August 2020 for use in patients 2 months of age or older in the treatment of spinal muscular atrophy (SMA). Set to be substantially cheaper than other available SMA therapies, risdiplam appears to provide a novel and relatively accessible treatment option for patients with SMA regardless of severity or type.
Risdiplam is a survival of motor neuron 2 (SMN2) splicing modifier.
light yellow powder to yellow powderCertificatesBasic Info-
Product Name:
Risdiplam
Other Name:7-amino-2,3-dihydro-1H-inden-4-ol;Risdiplam;RO7034067;RG7916;4H-Pyrido[1,2-a]pyrimidin-4-one, 7-(4,7-diazaspiro[2.5]oct-7-yl)-2-(2,8-dimethylimidazo[1,2-b]pyridazin-6-yl)-;2-(2,8-dimethylimidazo[1,2-b]pyridazin-6-yl)-7-(4,7-diazaspiro[2.5]octan-7-yl)-4H-pyrido[1,2-a]pyrimidin-4-one;Risdiplam (RG-7916, RO-7034067);2H4]-Risdiplam
CAS No.:1825352-65-5
Molecular Formula:C22H23N7O
InChIKeys:ASKZRYGFUPSJPN-UHFFFAOYSA-N
Molecular Weight:401.46
Exact Mass:401.46
EC Number:218-362-5
UNII:76RS4S2ET1
Color/Form:Light yellow to yellow
ATC Code:M09AX10|M - Musculo-skeletal system
Categories:
Characteristics-
Density:
1.50±0.1 g/cm3(Predicted)
PKA:9.41±0.20(Predicted)
-
-
Seller Information
-
Business Type:
Trader
-
Main Products:
PVC resin,pvc paste resin,melamine
-
Location:
Room 405, Unit 2, Building 1, Taiji Mansion, No. 38, Nanyang Road, Jinshui District, Zhengzhou City, Henan Province
-
Payment Terms:
TT against copy of documents,L/C
-
Average lead Time:
90 days
-
Total Annual Revenue:
$5 million-$10 million
-
Total Employees:
11-50
-
Year of Establishment:
2022
-
-
Inquiry History3 Inquiries
Country Product Purchase Quantity Date Posted 
India
Risdiplam
1 KG Feb 10, 2026 
Sweden
Risdiplam
100 G Jan 29, 2024
Sweden
Risdiplam
1 G Jan 29, 2024 Post an enquiry for this product
More from this Seller
-
-
![1-Bromo-3-chloropropane 99% see COA Kanbei]( "1-Bromo-3-chloropropane 99% see COA Kanbei")
-
1-Bromo-3-chloropropane 99% see COA Kanbei
Pharmaceutical Grade / 99%
-
-
-
![3-Mercaptopropionic acid 99% see COA kanbei]( "3-Mercaptopropionic acid 99% see COA kanbei")
-
3-Mercaptopropionic acid 99% see COA kanbei
Industrial Grade / 99%
-
-
-
![Imatinib Mesylate 99% see COA Kanbei kanbei]( "Imatinib Mesylate 99% see COA Kanbei kanbei")
-
Imatinib Mesylate 99% see COA Kanbei kanbei
Industrial Grade / 99%
-
-
-
![high purity hot sale Speciogynine 99% high quality see COA KANBEI]( "high purity hot sale Speciogynine 99% high quality see COA KANBEI")
-
high purity hot sale Speciogynine 99% high quality see COA KANBEI
Industrial Grade / 99%
-
-
-
![Molybdenum(IV) oxide 99% see COA kanbei]( "Molybdenum(IV) oxide 99% see COA kanbei")
-
Molybdenum(IV) oxide 99% see COA kanbei
Industrial Grade / 99%
-
